Milestone Scientific (MLSS) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
27 Jul, 2026Opening remarks and agenda
The meeting was held virtually to maximize attendance and accessibility for stockholders.
The agenda included the election of directors, amendments to the certificate of incorporation and equity plan, advisory vote on executive compensation, and auditor ratification.
Financial performance review
Fiscal year 2025 saw strengthened operational discipline, stabilized commercial execution, and new talent acquisition.
Focus remains on driving revenue growth, expanding market adoption, developing partnerships, and controlling costs in 2026.
Board and executive committee updates
Board members introduced: Eric C. Hines, Neal Goldman, Dr. Didier Demesmin, Greg Shilling, Kelly Ann Ulto, Dr. Dawood Sayed, and Benedetta Casamento.
Grassi & Co confirmed as independent registered public accounting firm for 2026.
Latest events from Milestone Scientific
- Q2 revenue up 22%, medical sales soared 231%, net loss narrowed, 2026 growth guidance reaffirmed.MLSS
Q2 2026 - Shareholders will vote on director elections, equity plan expansion, and key governance proposals.MLSS
Proxy filing - Virtual meeting to vote on directors, share increases, equity plan, pay, and auditor ratification.MLSS
Proxy filing - Virtual meeting to vote on directors, share increases, equity plan, pay, and auditor ratification.MLSS
Proxy filing - Resale registration for 15.9M shares after $2.15M private placement; faces funding and compliance risks.MLSS
Registration filing - Q1 2026 saw stable revenue, sharply reduced losses, and improved liquidity amid ongoing risks.MLSS
Q1 2026 - 2026 guidance projects double-digit growth and major CompuFlo gains, targeting break even by 2027.MLSS
Q4 2025 - Q3 2025 saw stable revenue, reduced costs, and improved net loss amid ongoing financial uncertainty.MLSS
Q3 2025 - Q2 net income turned positive on a $2M NOL sale, with strong e-commerce and margin gains.MLSS
Q2 2024